Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2016

24.08.2016 | Cataract

Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong

verfasst von: Alex Lap-Ki Ng, Wilson Wai-Tat Tang, Patrick Siu-Hung Li, Kenneth Kai-Wang Li

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose was to study the effect of introducing intracameral cefuroxime, which was compounded by a hospital pharmacy, on postoperative endophthalmitis in a tertiary eye centre in Hong Kong.

Methods

All cases that underwent cataract surgeries over a 12-year period (January 2004 to December 2015) were included. The routine use of intracameral cefuroxime at the end of cataract surgery was introduced at our centre after April 2010. All cefuroxime aliquots were prepared by the hospital pharmacy using an aseptic compounding technique. The rates of postoperative endophthalmitis before April 2010 (Group 1, no intracameral cefuroxime) and after April 2010 (Group 2, routine use of intracameral cefuroxime) were compared.

Results

A total of 30,428 eyes (7,332 in Group 1 and 23,096 in Group 2) were studied. Eight cases developed postoperative endophthalmitis (1.09 in 1000; 0.11 %) in Group 1 whereas no cases developed endophthalmitis (0 %) in Group 2. The rate of reduction was statistically significant (p < 0.0001). Seven out of eight cases of endophthalmitis were confirmed by positive culture. Organisms identified were Group G Streptococcus (two cases), Group B Streptococcus, Staphylococcus aureus, Serratia marcescens, and coagulase-negative Staphylococcus (two cases). Antibiotic susceptibility testing results were available in six cases. Four out of six organisms were susceptible to the penicillin group. No adverse events related to the use of intracameral cefuroxime were encountered.

Conclusions

The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong. The use of aseptic compounding to prepare cefuroxime aliquots by hospital pharmacy appeared to be safe and efficacious.
Literatur
1.
Zurück zum Zitat Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D (2005) Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139:983–987. doi:10.1016/j.ajo.2005.01.025 CrossRefPubMed Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D (2005) Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139:983–987. doi:10.​1016/​j.​ajo.​2005.​01.​025 CrossRefPubMed
3.
Zurück zum Zitat Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J (2015) Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol 93:303–317. doi:10.1111/aos.12684 CrossRefPubMed Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J (2015) Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol 93:303–317. doi:10.​1111/​aos.​12684 CrossRefPubMed
4.
Zurück zum Zitat ESCRS Study Group (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988. doi:10.1016/j.jcrs.2007.02.032 CrossRef ESCRS Study Group (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988. doi:10.​1016/​j.​jcrs.​2007.​02.​032 CrossRef
5.
7.
Zurück zum Zitat Garcia-Saenz MC, Arias-Puente A, Rodriguez-Caravaca G, Banuelos JB (2010) Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-years comparative study. J Cataract Refract Surg 36:203–207. doi:10.1016/j.jcrs.2009.08.023 CrossRefPubMed Garcia-Saenz MC, Arias-Puente A, Rodriguez-Caravaca G, Banuelos JB (2010) Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-years comparative study. J Cataract Refract Surg 36:203–207. doi:10.​1016/​j.​jcrs.​2009.​08.​023 CrossRefPubMed
8.
Zurück zum Zitat Katz G, Blum S, Leeva O, Axer-Siegel R, Moisseiev J, Tesler G, Ehrlich R (2015) Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience. Graefes Arch Clin Exp Ophthalmol 253:1729–1733. doi:10.1007/s00417-015-3009-z CrossRefPubMed Katz G, Blum S, Leeva O, Axer-Siegel R, Moisseiev J, Tesler G, Ehrlich R (2015) Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience. Graefes Arch Clin Exp Ophthalmol 253:1729–1733. doi:10.​1007/​s00417-015-3009-z CrossRefPubMed
9.
Zurück zum Zitat Rodriguez-Caravaca G, Garcia-Saenz MC, Villar-Del-Campo MC, Andres-Alba Y, Arias-Puente A (2013) Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. J Cataract Refract Surg 39:1399–1403. doi:10.1016/j.jcrs.2013.03.031 CrossRefPubMed Rodriguez-Caravaca G, Garcia-Saenz MC, Villar-Del-Campo MC, Andres-Alba Y, Arias-Puente A (2013) Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. J Cataract Refract Surg 39:1399–1403. doi:10.​1016/​j.​jcrs.​2013.​03.​031 CrossRefPubMed
10.
Zurück zum Zitat Jabbarvand M, Hashemian H, Khodaparast M, Jouhari M, Tabatabaei A, Rezaei S (2016) Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology 123:295–301. doi:10.1016/j.ophtha.2015.08.023 CrossRefPubMed Jabbarvand M, Hashemian H, Khodaparast M, Jouhari M, Tabatabaei A, Rezaei S (2016) Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology 123:295–301. doi:10.​1016/​j.​ophtha.​2015.​08.​023 CrossRefPubMed
12.
Zurück zum Zitat Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A (2015) Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg 41:1300–1305. doi:10.1016/j.jcrs.2015.01.014 CrossRefPubMed Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A (2015) Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg 41:1300–1305. doi:10.​1016/​j.​jcrs.​2015.​01.​014 CrossRefPubMed
13.
Zurück zum Zitat Grosso A, Pertile G, Marchini G, Scarpa G, Ceruti P, Prigione G, Romano MR, Bert F, Gili R, Panico C, Siliquini R, Engelbert M (2016) Adherence to European society for cataract and refractive surgery recommendations among Italian cataract surgeons: a survey. Eur J Ophthalmol. doi:10.5301/ejo.5000738 Grosso A, Pertile G, Marchini G, Scarpa G, Ceruti P, Prigione G, Romano MR, Bert F, Gili R, Panico C, Siliquini R, Engelbert M (2016) Adherence to European society for cataract and refractive surgery recommendations among Italian cataract surgeons: a survey. Eur J Ophthalmol. doi:10.​5301/​ejo.​5000738
14.
Zurück zum Zitat Meyer JJ, Polkinghorne P, McGhee CN (2016) Cataract surgery practices and endophthalmitis prophylaxis by New Zealand ophthalmologists. Clin Exp Ophthalmol. doi:10.1111/ceo.12712 Meyer JJ, Polkinghorne P, McGhee CN (2016) Cataract surgery practices and endophthalmitis prophylaxis by New Zealand ophthalmologists. Clin Exp Ophthalmol. doi:10.​1111/​ceo.​12712
15.
Zurück zum Zitat Behndig A, Cochener-Lamard B, Guell J, Kodjikian L, Mencucci R, Nuijts R, Pleyer U, Rosen P, Szaflik J, Tassignon MJ (2015) Surgical, antiseptic, and antibiotic practice in cataract surgery: results from the European observatory in 2013. J Cataract Refract Surg 41:2635–2643. doi:10.1016/j.jcrs.2015.06.031 CrossRefPubMed Behndig A, Cochener-Lamard B, Guell J, Kodjikian L, Mencucci R, Nuijts R, Pleyer U, Rosen P, Szaflik J, Tassignon MJ (2015) Surgical, antiseptic, and antibiotic practice in cataract surgery: results from the European observatory in 2013. J Cataract Refract Surg 41:2635–2643. doi:10.​1016/​j.​jcrs.​2015.​06.​031 CrossRefPubMed
17.
Zurück zum Zitat Group. EVS (1996) Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 122:830–846CrossRef Group. EVS (1996) Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 122:830–846CrossRef
19.
Zurück zum Zitat Garat M, Moser CL, Martin-Baranera M, Alonso-Tarres C, Alvarez-Rubio L (2009) Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-years study. J Cataract Refract Surg 35:637–642. doi:10.1016/j.jcrs.2008.12.023 CrossRefPubMed Garat M, Moser CL, Martin-Baranera M, Alonso-Tarres C, Alvarez-Rubio L (2009) Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-years study. J Cataract Refract Surg 35:637–642. doi:10.​1016/​j.​jcrs.​2008.​12.​023 CrossRefPubMed
23.
29.
Zurück zum Zitat Behndig A, Cochener B, Guell JL, Kodjikian L, Mencucci R, Nuijts RM, Pleyer U, Rosen P, Szaflik JP, Tassignon MJ (2013) Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg 39:1421–1431. doi:10.1016/j.jcrs.2013.06.014 CrossRefPubMed Behndig A, Cochener B, Guell JL, Kodjikian L, Mencucci R, Nuijts RM, Pleyer U, Rosen P, Szaflik JP, Tassignon MJ (2013) Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg 39:1421–1431. doi:10.​1016/​j.​jcrs.​2013.​06.​014 CrossRefPubMed
Metadaten
Titel
Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong
verfasst von
Alex Lap-Ki Ng
Wilson Wai-Tat Tang
Patrick Siu-Hung Li
Kenneth Kai-Wang Li
Publikationsdatum
24.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3473-0

Weitere Artikel der Ausgabe 10/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.